Re: from IR/Chris

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

fuzzyjr

Rank: Vice President [?]

Points: 5268 [?]

Votes: 36 Score: 3.1 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: from IR/Chris

in response to

Re: from IR/Chris

KayakerBC

posted on Dec 15, 2022 03:10PM

"Hopefully a sale in the next couple of years. And $$$ in our pock"

Yes,ive always hoped for a shorter time frame as every year we seem to say another couple years but the more i play in biotech field the more i tend to agree with you.